Skip to main content

Breadcrumb

  1. Home

A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)

Submitted by Anonymous (not verified) on Mon, 01/08/2024 - 19:37
  • Read more about A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)

(VELA) Study of BLU-222 in Advanced Solid Tumors

Submitted by Anonymous (not verified) on Mon, 01/08/2024 - 19:37
  • Read more about (VELA) Study of BLU-222 in Advanced Solid Tumors

Non-Invasive Ventilation Versus Neurally-Adjusted Ventilatory Assistance (NAVA) for the Treatment of Bronchiolitis

Submitted by Anonymous (not verified) on Tue, 12/19/2023 - 14:59
  • Read more about Non-Invasive Ventilation Versus Neurally-Adjusted Ventilatory Assistance (NAVA) for the Treatment of Bronchiolitis

Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors

Submitted by Anonymous (not verified) on Tue, 12/19/2023 - 14:59
  • Read more about Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

Submitted by Anonymous (not verified) on Tue, 12/19/2023 - 14:59
  • Read more about A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

Submitted by Anonymous (not verified) on Tue, 12/19/2023 - 14:59
  • Read more about Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Submitted by Anonymous (not verified) on Tue, 12/19/2023 - 14:59
  • Read more about A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer

Submitted by Anonymous (not verified) on Tue, 12/19/2023 - 14:58
  • Read more about Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer

Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma

Submitted by Anonymous (not verified) on Tue, 12/19/2023 - 14:58
  • Read more about Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

Submitted by Anonymous (not verified) on Tue, 12/19/2023 - 14:57
  • Read more about A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 31
  • Page 32
  • Page 33
  • Page 34
  • Page 35
  • Page 36
  • Page 37
  • Page 38
  • Page 39
  • …
  • Next page Next
  • Last page Last
Subscribe to